| A cellular model of Brugada syndrome with SCN10A variants using human-induced pluripotent stem cell-derived cardiomyocytes I El-Battrawy, S Albers, L Cyganek, Z Zhao, H Lan, X Li, Q Xu, ... EP Europace 21 (9), 1410-1421, 2019 | 37 | 2019 |
| Studying Brugada syndrome with an SCN1B variants in human-induced pluripotent stem cell-derived cardiomyocytes I El-Battrawy, J Müller, Z Zhao, L Cyganek, R Zhong, F Zhang, ... Frontiers in Cell and Developmental Biology 7, 261, 2019 | 33 | 2019 |
| Established and emerging lipid-lowering drugs for primary and secondary cardiovascular prevention DT Michaeli, JC Michaeli, S Albers, T Boch, T Michaeli American Journal of Cardiovascular Drugs 23 (5), 477-495, 2023 | 25 | 2023 |
| Medical education and mental health during COVID-19: a survey across 9 countries D Michaeli, G Keough, F Perez-Dominguez, F Polanco-Ilabaca, ... International journal of medical education 13, 35, 2022 | 24 | 2022 |
| Socio-economic burden of disease: Survivorship costs for bladder cancer JC Michaeli, T Boch, S Albers, T Michaeli, DT Michaeli Journal of Cancer Policy 32, 100326, 2022 | 15 | 2022 |
| Deciphering the pathogenic role of a variant with uncertain significance for short QT and Brugada syndromes using gene‐edited human‐induced pluripotent stem cell‐derived … I El‐Battrawy, H Lan, L Cyganek, L Maywald, R Zhong, F Zhang, Q Xu, ... Clinical and Translational Medicine 11 (12), e646, 2021 | 13 | 2021 |
| Special FDA designations for drug development: orphan, fast track, accelerated approval, priority review, and breakthrough therapy DT Michaeli, T Michaeli, S Albers, T Boch, JC Michaeli The European Journal of Health Economics, 1-19, 2023 | 10 | 2023 |
| Versorgungsrealität in Deutschland: ein Auszug aus dem Schulterendoprothesenregister der Deutschen Vereinigung für Schulter-und Ellenbogenchirurgie eV (DVSE) J Kircher, B Ohly, S Albers, F Kirchner, R Hudek, P Magosch Obere Extremität 17 (2), 92-98, 2022 | 8 | 2022 |
| Clinical benefit, development, innovation, trials, epidemiology, and price for cancer drugs and indications with multiple special FDA designations DT Michaeli, T Michaeli, S Albers, JC Michaeli JNCI: Journal of the National Cancer Institute 116 (2), 216-229, 2024 | 7 | 2024 |
| Anterolateral acromioplasty does not change the critical shoulder angle and acromion index in a clinically relevant amount S Thiesemann, F Kirchner, MF Fal, S Albers, J Kircher Arthroscopy: The Journal of Arthroscopic & Related Surgery 38 (11), 2960-2968, 2022 | 6 | 2022 |
| A Preclinical Study on Brugada Syndrome with a CACNB2 Variant Using Human Cardiomyocytes from Induced Pluripotent Stem Cells R Zhong, T Schimanski, F Zhang, H Lan, A Hohn, Q Xu, M Huang, Z Liao, ... International Journal of Molecular Sciences 23 (15), 8313, 2022 | 6 | 2022 |
| The healthcare labor shortage: Practice, theory, evidence, and ways forward DT Michaeli, JC Michaeli, S Albers, T Michaeli Theory, Evidence, and Ways Forward (March 26, 2022), 2022 | 5 | 2022 |
| Association between clinical trial design characteristics and treatment effect estimates: A meta-analysis of randomized-controlled and single-arm trials supporting the FDA … DT Michaeli, T Michaeli, S Albers, JC Michaeli Available at SSRN 4546126, 2023 | 3 | 2023 |
| Midterm outcomes of autologous bridging of rotator cuff tears with an autologous tendon patch (TEAR patch) S Albers, Y Ono, F Kirchner, MF Fal, J Kircher Journal of Shoulder and Elbow Surgery 33 (2), 312-320, 2024 | 1 | 2024 |
| Arthroscopic Posterior HAGL Repair Using a Direct Transaxillary Portal S Albers, MF Fal, J Kircher Arthroscopy Techniques 12 (7), e1027-e1031, 2023 | 1 | 2023 |
| How to deal with posterior glenoid erosion in anatomic total shoulder arthroplasty S Albers, R Hudek, J Kircher Obere Extremität 17 (2), 74-83, 2022 | 1 | 2022 |
| Socio‐economic burden of disease: survivorship costs for renal cell carcinoma JC Michaeli, DT Michaeli, T Boch, S Albers, T Michaeli European Journal of Cancer Care 31 (3), e13569, 2022 | 1 | 2022 |
| Clinical trial design and treatment effects: a meta-analysis of randomised controlled and single-arm trials supporting 437 FDA approvals of cancer drugs and indications DT Michaeli, T Michaeli, S Albers, JC Michaeli BMJ Evidence-Based Medicine, 2024 | | 2024 |
| 238P Breast cancer drugs: FDA approval, development time, efficacy, clinical benefits, innovativeness, trials, endpoints, and price JC Michaeli, CT Michaeli, D Trapani, S Albers, D Dannehl, R Würstlein, ... ESMO Open 9, 2024 | | 2024 |
| Arthroscopic subscapularis repair using the subscapularis interlocking (SICK)-stitch technique leads to restoration of clinical function with low complication and revision rates F Kirchner, Y Ono, S Albers, M Junker, MF Fal, J Kircher JSES international 8 (1), 67-74, 2024 | | 2024 |
